Anti-AT1R Ab are agonistic non-complement-fixing immunoglobulins that promote malignant hypertension by over-activating AT1R (47); moreover, anti-AT1R Ab can induce microvascular inflammation and coagulation by stimulating NF-kB pathway and tissue factor expression by EC (58). The gene discussed is NFKB1; the disease is malignant hypertension.